Prognostic factors for treatment outcome in advanced non-small-cell lung cancer (NSCLC): retrospective study and preliminary results

被引:0
|
作者
Grigorescu, AC [1 ]
Dinu, B [1 ]
Boldeanu, C [1 ]
机构
[1] Inst Oncol Bucharest, Bucharest, Romania
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:307 / 308
页数:2
相关论文
共 50 条
  • [41] Resection of Isolated Brain Metastasis Improves Outcome of Non-Small-Cell Lung Cancer (NSCLC) Patients: A Retrospective Multicenter Study
    Fuchs, Julia
    Fruh, Martin
    Papachristofilou, Alexandros
    Bubendorf, Lukas
    Schill, Catherine
    Jost, Lorenz
    Zippelius, Alfred
    Rothschild, Sacha
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S771 - S771
  • [42] PRELIMINARY RESULTS OF ANTITUMOR ACTIVITY OF GEFITINIB (IRESSA™) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) ON A COMPASSIONATE USE PROTOCOL
    Di Emidio, K.
    Barbieri, F.
    Bavieri, M.
    Pifferi, M.
    Marchioni, A.
    Fabbri, L. M.
    Conte, P. F.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 32 - 32
  • [43] Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Kilinc, Faruk
    Isikdogan, Abdurrahman
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2014, 20 (02) : 62 - 68
  • [44] Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?
    Pallis, A. G.
    Gridelli, C.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 (05) : 436 - 441
  • [45] Is there a need for new prognostic factors in non-small-cell lung cancer?
    Pirker, R
    [J]. ONKOLOGIE, 1998, 21 (03): : 248 - 248
  • [46] Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab
    Venturella, Fabio
    Cancellieri, Giulia
    Giammanco, Marco
    Almerico, Anna Maria
    Aleo, Igor Daniele
    Liga, Anastasia Valentina
    Mortillaro, Francesca
    Mistretta, Irene
    [J]. JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2023, 96 (01):
  • [47] Prognostic factors in stage III non-small-cell lung cancer
    Ademuyiwa, Foluso O.
    Johnson, Cynthia S.
    White, Angela S.
    Breen, Timothy E.
    Harvey, Jayme
    Neubauer, Marcus
    Hanna, Nasser H.
    [J]. CLINICAL LUNG CANCER, 2007, 8 (08) : 478 - 482
  • [48] Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
    Tibaldi, Carmelo
    Mazzoni, Francesca
    Scotti, Vieri
    Vasile, Enrico
    Pozzessere, Daniele
    Stasi, Irene
    Camerini, Andrea
    Federici, Francesca
    Meoni, Giulia
    Caparello, Chiara
    Turrini, Marianna
    Rossi, Virginia
    Ciccone, Lucia Pia
    Pecora, Irene
    Fantechi, Beatrice
    Antonuzzo, Lorenzo
    Giannarelli, Diana
    Baldini, Editta
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (07) : 1278 - 1285
  • [49] Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study
    Fuchs, Julia
    Frueh, Martin
    Papachristofilou, Alexandros
    Bubendorf, Lukas
    Haeuptle, Pirmin
    Jost, Lorenz
    Zippelius, Alfred
    Rothschild, Sacha, I
    [J]. PLOS ONE, 2021, 16 (06):
  • [50] Prognostic factors for survival of non-small cell lung cancer (NSCLC). Results of a prospective multicenter study.
    Fuentes, R
    Bover, I
    Canals, E
    Rifa, J
    Moreno, V
    Barreiro, E
    Beltran, M
    Viladiu, P
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 : PO23 - PO23